Dr. John Dick gave a great talk yesterday on cancer stem cells here at ISSCR 2016. Below I summarize his talk and as always with these meeting blogs, the post is not polished and is more of a stream of the speaker’s main points. He started out broadly with a nice introduction to this area of […]
Thought provoking talk from John Dick at ISSCR 2016 on cancer stem cells Read More »
Something very unusual and positive just happened at this year’s ISSCR meeting. Every year in December I give out an award for the Stem Cell Person of the Year to the individual with the strongest positive impact in the stem cell field generated specifically from outside-the-box thinking and actions. Dr. Jeanne Loring was the recipient in
At ISSCR 2016, $2,000 donation to Summit For Stem Cell patient group Read More »
ISSCR 2016’s first plenary session is focused on stem cells & cancer. I was really excited about this one even before the meeting as this topic is a major focus of my own lab. Here’s the lineup for this plenary with great expertise in stem cells & cancer from across the globe: President’s Address: Sean Morrison, Children’s
Austin Smith talk at ISSCR 2016: a ground state inhibitor pathway Read More »
Starting tomorrow I’m going to be at the ISSCR 2016 meeting live blogging it in San Francisco. The annual ISSCR meeting is a great place to hear about all the latest research from basic findings to reports on pre-clinical and clinical studies. There are always valuable and unique insights from chatting with people too. I
Live Blogging ISSCR 2016 SFO Read More »
A committee of the International Society for Stem Cell Research (ISSCR) did one heck of a document dump yesterday on stem cell policy, releasing a whole bunch of policy recommendations on stem cells and more. The torrent from ISSCR included a 37-page policy statement itself as well as several papers in top journals including the
ISSCR Releases Flood of Stem Cell Policy Docs Read More »
I recently chatted with Sean Morrison, current President of ISSCR, on his goals for the Society, where the stem cell field stands today, top challenges, and the future. 2020 update: read my new interview with Sean on cell therapies for COVID-19. What are your goals for your tenure as President of ISSCR? SM: ISSCR is the
ISSCR President Sean Morrison on challenges and future of stem cell field Read More »
ISSCR Chat By Michael Cea Jeanne Loring of the Scripps Research Institute in La Jolla, California kindly sat down with me at the ISSCR annual meeting for a broad discussion of her history, views on the field and developments in the science. I found Jeanne a refreshing character, as I did a number of others I was
Michael Cea ISSCR chat with Jeanne Loring on stem cell field Read More »
What’s on your mind on this Monday morning and are you caffeinated enough yet? Depending on where you live it may even be time for dinner, bed, or already early Tuesday. Here are some Monday musings… To get safe and effective stem cell treatments to patients in a responsible, compliant manner you need commercial efforts
Monday morning musings: stocks, ISSCR, grants, CRISPR, New Book Read More »
The path to the clinic is a slow and arduous activity, frustrating not only to the researcher and patient, but investors and biotech companies. Successful clinical translation of technologies requires a balance of science, streamlined translation and funding. To develop fantastic science and then realise the most important components cannot be adapted to the clinical
Biotech Talks #ISSCR2015: StemCells Inc, Semma, ViaCyte, & Le Blanc Read More »
Organoids are pretty big in stem cells right now with the last couple of years having attracted a lot of media attention on mini lungs, mini brains, mini kidneys, mini guts and more, giving the impression that scientists know how to specify and organise cells into mini functional organs in the lab. Organoids have become
Carla Kim & Hans Clevers talks on organoids at #ISSCR2015 Read More »